Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.49 |
| ▸ | HTR2C | P28335 | 3/20 | 0.49 |
| ▸ | HTR7 | P34969 | 3/20 | 0.49 |
| ▸ | HTR6 | P50406 | 2/20 | 0.49 |
| ▸ | CCR3 | P51677 | 5/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.42 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7724008 | 1.00 | HTR2A (0.49) | HTR2AHTR2CHTR7HTR6CCR3 | |
| SCHEMBL7725264 | 0.90 | SIGMAR1 (0.53) | HTR2ACCR3DRD2DRD4SIGMAR1 | |
| SCHEMBL7725261 | 0.90 | SIGMAR1 (0.53) | HTR2ACCR3DRD2DRD4SIGMAR1 | |
| SCHEMBL7719861 | 0.87 | HTR2A (0.50) | HTR2AHTR2CHTR7HTR6CCR3 | |
| SCHEMBL7719857 | 0.87 | HTR2A (0.50) | HTR2AHTR2CHTR7HTR6CCR3 | |
| SCHEMBL7724241 | 0.87 | HTR2A (0.53) | HTR2AHTR2CHTR7HTR6CCR3 | |
| SCHEMBL7724243 | 0.87 | HTR2A (0.53) | HTR2AHTR2CHTR7HTR6CCR3 | |
| SCHEMBL7724354 | 0.82 | HTR2A (0.42) | HTR2AHTR2CHTR7HTR6CCR3 | |
| SCHEMBL7724358 | 0.82 | HTR2A (0.42) | HTR2AHTR2CHTR7HTR6CCR3 | |
| SCHEMBL7724337 | 0.81 | KMT2A (0.51) | HTR2AHTR2CHTR7HTR6CCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6468998-B1 | ANTAGONIZE SEROTONIN 2 RECEPTORS, SUPPRESS PLATELET AGGREGATION, IMPROVE PERIPHERAL CIRCULATION AND PROMOTE LACHRYMATION | MITSUBISHI PHARMA CORPORATION (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-1125922-A1 | PYRROLIDINE COMPOUNDS AND MEDICINAL UTILIZATION THEREOF | Welfide Corporation (JP) | 2001-08-22 | — | — | EP | disclosed |